Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study
J Eur Acad Dermatol Venereol
.
2024 Oct 15.
doi: 10.1111/jdv.20373.
Online ahead of print.
Authors
A Bagit
1
,
K Maliyar
2
,
M Mansour
2
,
J R Georgakopoulos
2
,
B Rankin
3
,
Y Lytvyn
1
2
,
H Zaaroura
2
,
Y J Park
1
,
E Wang
4
,
A Mufti
2
5
,
T Torres
6
7
,
A M Le
6
,
R Vender
8
,
V H Prajapati
3
9
10
11
12
13
,
J Yeung
2
5
14
15
Affiliations
1
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
2
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
3
Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
4
Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
5
Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
6
Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal.
7
Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
8
Dermatrials Research Inc. and Venderm Consulting, Hamilton, Ontario, Canada.
9
Dermatology Research Institute, Calgary, Alberta, Canada.
10
Probity Medical Research, Calgary, Alberta, Canada.
11
Skin Health & Wellness Centre, Calgary, Alberta, Canada.
12
Section of Community Pediatrics, University of Calgary, Calgary, Alberta, Canada.
13
Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
14
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
15
Probity Medical Research, Toronto, Ontario, Canada.
PMID:
39403817
DOI:
10.1111/jdv.20373
No abstract available
Publication types
Letter